A newsletter by Reuters and Westlaw |
|
|
-
The 21-year claims program is designed to sweep in future cancer claims and offer payouts to people who used Roundup before February 17, 2026, and develop cancer in the future. The company did not remove glyphosate, the active ingredient in Roundup that plaintiffs allege is carcinogenic, from its residential products until 2023.
-
It’s not clear yet how many plaintiffs firms support the deal. Bayer can terminate the deal if too few firms sign on, but the company won't say how many firms can opt out before the agreement is canceled.
-
The U.S. Supreme Court is also in play. Bayer has a case before the court scheduled for an April 27 oral argument that’s a key part of the company's effort to beat these claims. The court will decide whether Bayer can be sued under state law for failing to warn about the alleged cancer risks associated with Roundup, when federal regulations do not require a warning label on the product.
-
Read more about the proposed settlement here.
|
-
Environment: U.S. District Judge Haywood Gilliam in Oakland will hear arguments in a lawsuit that could decide the fate of California's vehicle-emissions rules, which would have required 100% of all new vehicles to be electric by 2035. Congress last year struck down the California regulations, a move the state is challenging. Thursday's hearing is on the Trump administration's motion to dismiss the lawsuit.
- Labor: Chief U.S. District Judge Denise Casper in Boston will consider whether to temporarily block UPS from offering a new round of buyout packages to its drivers through a workforce-cutting program opposed by the International Brotherhood of Teamsters union.
-
Crypto: Manpreet Kohli, the chief executive of cryptocurrency company Saitana, will urge U.S. District Judge Angel Kelley in Boston to dismiss an indictment accusing him of manipulating trading of its tokens and secretly selling them, enabling his firm at one point to obtain a market value of $7.5 billion.
-
Abortion: A Texas appeals court will hear arguments in a civil lawsuit brought by the state against Maria Rojas, a midwife accused of providing abortions in violation of the state’s near-total abortion ban. The lower court issued an injunction, shutting down the three clinics where she provided maternal healthcare.
- Securities: The Arizona Supreme Court will hear arguments over whether juryless trials before the state’s securities regulator is constitutional. The lower court found that it was.
-
Criminal: A final pretrial conference is scheduled before an Iranian-born engineer is slated to face trial on charges related to a deadly drone attack on a U.S. military base in Jordan carried out by Iran-backed militants in 2024. Mahdi Sadeghi, who worked at the semiconductor company Analog Devices, is charged in Boston with engaging in a scheme to violate U.S. export control and sanctions laws.
|
Court calendars are subject to last-minute docket changes. |
|
|
- President Trump nominated a lawyer who was part of his legal team in a landmark presidential immunity case before the U.S. Supreme Court, to serve as a judge on the St. Louis-based 8th Circuit. Read more about the nomination here.
-
Erin Hawley, a top attorney in the legal fight to restrict access to the abortion pill drug known as mifepristone, joined conservative law firm Lex Politica as chair of its U.S. Supreme Court and appellate litigation practice.
|
|
|
"Not a single tax return signed by Mr. Goldstein under penalty of perjury is correct -- not one."
|
—Prosecutor Sean Beaty urging a jury to find prominent U.S. Supreme Court lawyer Tom Goldstein guilty of tax and financial crimes, as a lengthy trial wrapped up over Goldstein's accounting of millions of dollars he won and lost in his double life as a high-stakes poker player. Goldstein pleaded not guilty to 16 counts of tax evasion. Jury deliberations are expected to begin today. Read more about closing arguments here.
|
|
|
-
U.S. District Judge Arun Subramanian in Manhattan rejected Live Nation's bid to dismiss a lawsuit by the federal government and many U.S. states accusing the company of violating antitrust law by trying to dominate the live concert industry and inflate prices.
|
|
|
|
